Enzo Biochem CEO Elazar Rabbani's 2011 pay rises 1% to $1.3M
Enzo Biochem reports 2011 executive compensation
By ExecPay News
Published: November 28, 2011
Enzo Biochem reported fiscal year 2011 executive compensation information on November 28, 2011.
In 2011, six executives at Enzo Biochem received on average a compensation package of $632K, a 19% decrease compared to previous year.
Average pay of disclosed executives at Enzo Biochem
Elazar Rabbani, Chief Executive Officer, received $1.3M in total, which increased by 1% compared to 2010. 42% of Rabbani's compensation, or $552K, was in salary. Rabbani also received $300K in bonus, $233K in non-equity incentive plan, $61K in stock awards, as well as $173K in other compensation.
Barry W. Weiner, Chief Financial Officer, received a compensation package of $1.1M, which decreased by 1% compared to previous year. 46% of the compensation package, or $489K, was in salary.
Andrew R. Crescenzo, Senior Vice President of Finance, earned $399K in 2011, a 8% increase compared to previous year.
David C. Goldberg, Vice President Corporate Development and Interim General Manager Enzo Clinical Labs, received $356K in 2011.
Kevin Krenitsky, Former President of Enzo Clinical Labs, earned $326K in 2011, a 11% decrease compared to previous year.
Andrew P. Whiteley, Chief Operating Officer, received $325K in 2011.
Enzo Biochem's fiscal year ends on July 31.
Related executives
Elazar Rabbani
Enzo Biochem
Chief Executive Officer
Barry Weiner
Enzo Biochem
President and Treasurer
Andrew Whiteley
Enzo Biochem
Chief Operating Officer
Andrew Crescenzo
Enzo Biochem
Senior Vice President of Finance
David Goldberg
Enzo Biochem
Vice President Corporate Development and Interim General Manager, Enzo Clinical Labs
Kevin Krenitsky
Enzo Biochem
Former President of Enzo Clinical Labs
You may also like
Source: SEC filing on November 28, 2011.